134 related articles for article (PubMed ID: 3646455)
1. Isolation of HTLV III/LAV from drug addicts in Palermo.
Romano N; Portera M; Vitale F; Russo Alesi D; Torregrossa MV; Perrera G
Microbiologica; 1987 Jan; 10(1):73-80. PubMed ID: 3646455
[TBL] [Abstract][Full Text] [Related]
2. [Isolation of LAV/HTLV III from tears of patients with the ARC syndrome].
Baudouin C; Laffont C; Cottalorda J; De Galleani B; Gastaud P; Lefebvre JC
J Fr Ophtalmol; 1987; 10(2):135-9. PubMed ID: 2440938
[TBL] [Abstract][Full Text] [Related]
3. Detection and isolation of an acquired immune deficiency syndrome (AIDS)-related virus (HTLV-III/LAV) from a Japanese boy with AIDS-related complex.
Yoshiyama H; Koyanagi Y; Nakashima H; Ishihara T; Uchino F; Harada S; Okino F; Kajii T; Yamamoto N
Jpn J Cancer Res; 1986 Jan; 77(1):16-20. PubMed ID: 2420772
[TBL] [Abstract][Full Text] [Related]
4. Isolation of HIV from Israeli patients and asymptomatic carriers.
Vonsover A; Gotlieb-Stematsky T; Alexander R; Fogel A; Rubinstein E; Handzel ZT; Burstein R; Bentwich Z
Isr J Med Sci; 1988 Mar; 24(3):141-4. PubMed ID: 2453484
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of HTLV III/LAV and other viral antibodies in normal and at risk populations.
Ferrante P; Nardi G; Zanchetta N; Salvioni PM; Pagano A
Boll Ist Sieroter Milan; 1986; 65(5):357-60. PubMed ID: 3030363
[TBL] [Abstract][Full Text] [Related]
6. [Immunological abnormalities in intravenous drug addicts in relation to contact with the HTLV III/LAV virus].
Besalduch Vidal J; Sanchís Cervera J; Miralles Bacete E; Vila Pastor B; Balaguer Muñoz H; Gil García S
Med Clin (Barc); 1987 May; 88(18):715-8. PubMed ID: 3497319
[No Abstract] [Full Text] [Related]
7. New human and simian HIV-related retroviruses possess functional transactivator (tat) gene.
Arya SK; Beaver B; Jagodzinski L; Ensoli B; Kanki PJ; Albert J; Fenyo EM; Biberfeld G; Zagury JF; Laure F
Nature; 1987 Aug 6-12; 328(6130):548-50. PubMed ID: 3039372
[TBL] [Abstract][Full Text] [Related]
8. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].
Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M
Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856
[No Abstract] [Full Text] [Related]
9. Recovery of HIV-related retroviruses from Italian patients with AIDS or AIDS-related complex and from asymptomatic at-risk individuals.
Rossi GB; Verani P; Macchi B; Federico M; Orecchia A; Nicoletti L; Buttò S; Lazzarin A; Mariani G; Ippolito G
Ann N Y Acad Sci; 1987; 511():390-400. PubMed ID: 3439718
[TBL] [Abstract][Full Text] [Related]
10. [Occurrence of HTLV-III infection and related clinical forms in a homogeneous group of drug addicts. Significance of immunologic changes and evaluation of risk factors].
Tassinari MC; Gualandi M; Guerra G; Barbieri D; Benassi N; Lazzarato M; Dallara G; Gallerani M
Recenti Prog Med; 1986 Oct; 77(10):461-5. PubMed ID: 3547522
[No Abstract] [Full Text] [Related]
11. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses.
Margolick JB; Volkman DJ; Folks TM; Fauci AS
J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285
[TBL] [Abstract][Full Text] [Related]
12. Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts.
Lazzarin A; Crocchiolo P; Galli M; Uberti Foppa C; Caredda F; Re T; Moroni M
Boll Ist Sieroter Milan; 1987; 66(1):9-13. PubMed ID: 3304347
[TBL] [Abstract][Full Text] [Related]
13. Further isolation of HIV strains in Palermo: some biological properties of the new isolates.
Lupo G; Spadaro F; Portera M; Torregrossa MV; Russo Alesi D; Vitale F; Romano N
Microbiologica; 1988 Oct; 11(4):329-37. PubMed ID: 3063924
[TBL] [Abstract][Full Text] [Related]
14. Genetic comparison of LAV-related isolates.
Magasiny S; Spire B; Rey F; Barre-Sinoussi F; Chermann JC
Cancer Detect Prev Suppl; 1987; 1():493-9. PubMed ID: 2826003
[TBL] [Abstract][Full Text] [Related]
15. Phosphonoformate (foscarnet): a pilot study in AIDS and AIDS related complex.
Farthing CF; Dalgleish AG; Clark A; McClure M; Chanas A; Gazzard BG
AIDS; 1987 May; 1(1):21-5. PubMed ID: 2962589
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
[No Abstract] [Full Text] [Related]
17. HTLV-III: the etiologic agent of AIDS.
Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
[TBL] [Abstract][Full Text] [Related]
18. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS.
Gartner S; Markovits P; Markovitz DM; Betts RF; Popovic M
JAMA; 1986 Nov; 256(17):2365-71. PubMed ID: 3490587
[TBL] [Abstract][Full Text] [Related]
19. Structural and epidemiological features of primate lymphotropic retroviruses.
Hunsmann G; Schneider J; Bayer H; Jurkiewicz E; Yamamoto N
Princess Takamatsu Symp; 1984; 15():109-18. PubMed ID: 6100632
[TBL] [Abstract][Full Text] [Related]
20. Presence of HTLV-III in tears and cells from the eyes of AIDS patients.
Ablashi DV; Sturzenegger S; Hunter EA; Palestine AG; Fujikawa LS; Kim MK; Nussenblatt RB; Markham PD; Salahuddin SZ
J Exp Pathol; 1987; 3(4):693-703. PubMed ID: 3483881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
